세계의 정맥 용액 합성기 시장예측 2020년-2025년

■ 영문 제목 : Global Intravenous Solution Compounder Market Growth 2020-2025

LP Information가 발행한 조사보고서이며, 코드는 LPI20JL010317 입니다.■ 상품코드 : LPI20JL010317
■ 조사/발행회사 : LP Information
■ 발행일 : 2020년6월
■ 페이지수 : 131
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료기기
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD3,660 ⇒환산₩4,099,200견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산₩6,148,800견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산₩8,198,400견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
본 조사보고서는 정맥 용액 합성기의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측, 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 각지역의 종류별 시장규모 (Countertop Intravenous Solution Compounder, Standalone Intravenous Solution Compounder)와 용도별 시장규모 (Hospital, Clinic, Others) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 정맥 용액 합성기 시장 점유율
- 지역별 정맥 용액 합성기 시장규모
- 각지역의 종류별 시장규모 (Countertop Intravenous Solution Compounder, Standalone Intravenous Solution Compounder)
- 각지역의 용도별 시장규모 (Hospital, Clinic, Others)
- 미주의 정맥 용액 합성기 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 정맥 용액 합성기 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 정맥 용액 합성기 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 정맥 용액 합성기 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 정맥 용액 합성기 시장예측 (2021년-2025년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론
■ 보고서 개요

According to this study, over the next five years the Intravenous Solution Compounder market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravenous Solution Compounder business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Solution Compounder market by type, application, key manufacturers and key regions and countries.

This study considers the Intravenous Solution Compounder value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Countertop Intravenous Solution Compounder
Standalone Intravenous Solution Compounder

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ARxIUM
Baxter
B.Braun
Grifols
ICU Medical
Pfizer
Omnicell

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Intravenous Solution Compounder consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Intravenous Solution Compounder market by identifying its various subsegments.
Focuses on the key global Intravenous Solution Compounder manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Intravenous Solution Compounder with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Intravenous Solution Compounder submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

■ 보고서 목차

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Solution Compounder Consumption 2015-2025
2.1.2 Intravenous Solution Compounder Consumption CAGR by Region
2.2 Intravenous Solution Compounder Segment by Type
2.2.1 Countertop Intravenous Solution Compounder
2.2.2 Standalone Intravenous Solution Compounder
2.3 Intravenous Solution Compounder Consumption by Type
2.3.1 Global Intravenous Solution Compounder Consumption Market Share by Type (2015-2020)
2.3.2 Global Intravenous Solution Compounder Revenue and Market Share by Type (2015-2020)
2.3.3 Global Intravenous Solution Compounder Sale Price by Type (2015-2020)
2.4 Intravenous Solution Compounder Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Intravenous Solution Compounder Consumption by Application
2.5.1 Global Intravenous Solution Compounder Consumption Market Share by Type (2015-2020)
2.5.2 Global Intravenous Solution Compounder Value and Market Share by Type (2015-2020)
2.5.3 Global Intravenous Solution Compounder Sale Price by Type (2015-2020)

3 Global Intravenous Solution Compounder by Company
3.1 Global Intravenous Solution Compounder Sales Market Share by Company
3.1.1 Global Intravenous Solution Compounder Sales by Company (2018-2020)
3.1.2 Global Intravenous Solution Compounder Sales Market Share by Company (2018-2020)
3.2 Global Intravenous Solution Compounder Revenue Market Share by Company
3.2.1 Global Intravenous Solution Compounder Revenue by Company (2018-2020)
3.2.2 Global Intravenous Solution Compounder Revenue Market Share by Company (2018-2020)
3.3 Global Intravenous Solution Compounder Sale Price by Company
3.4 Global Intravenous Solution Compounder Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Intravenous Solution Compounder Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Intravenous Solution Compounder Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Intravenous Solution Compounder by Regions
4.1 Intravenous Solution Compounder by Regions
4.2 Americas Intravenous Solution Compounder Consumption Growth
4.3 APAC Intravenous Solution Compounder Consumption Growth
4.4 Europe Intravenous Solution Compounder Consumption Growth
4.5 Middle East & Africa Intravenous Solution Compounder Consumption Growth

5 Americas
5.1 Americas Intravenous Solution Compounder Consumption by Countries
5.1.1 Americas Intravenous Solution Compounder Consumption by Countries (2015-2020)
5.1.2 Americas Intravenous Solution Compounder Value by Countries (2015-2020)
5.2 Americas Intravenous Solution Compounder Consumption by Type
5.3 Americas Intravenous Solution Compounder Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Intravenous Solution Compounder Consumption by Regions
6.1.1 APAC Intravenous Solution Compounder Consumption by Regions (2015-2020)
6.1.2 APAC Intravenous Solution Compounder Value by Regions (2015-2020)
6.2 APAC Intravenous Solution Compounder Consumption by Type
6.3 APAC Intravenous Solution Compounder Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Intravenous Solution Compounder by Countries
7.1.1 Europe Intravenous Solution Compounder Consumption by Countries (2015-2020)
7.1.2 Europe Intravenous Solution Compounder Value by Countries (2015-2020)
7.2 Europe Intravenous Solution Compounder Consumption by Type
7.3 Europe Intravenous Solution Compounder Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Intravenous Solution Compounder by Countries
8.1.1 Middle East & Africa Intravenous Solution Compounder Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Intravenous Solution Compounder Value by Countries (2015-2020)
8.2 Middle East & Africa Intravenous Solution Compounder Consumption by Type
8.3 Middle East & Africa Intravenous Solution Compounder Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Intravenous Solution Compounder Distributors
10.3 Intravenous Solution Compounder Customer

11 Global Intravenous Solution Compounder Market Forecast
11.1 Global Intravenous Solution Compounder Consumption Forecast (2021-2025)
11.2 Global Intravenous Solution Compounder Forecast by Regions
11.2.1 Global Intravenous Solution Compounder Forecast by Regions (2021-2025)
11.2.2 Global Intravenous Solution Compounder Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Intravenous Solution Compounder Forecast by Type
11.8 Global Intravenous Solution Compounder Forecast by Application

12 Key Players Analysis
12.1 ARxIUM
12.1.1 Company Information
12.1.2 Intravenous Solution Compounder Product Offered
12.1.3 ARxIUM Intravenous Solution Compounder Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 ARxIUM Latest Developments
12.2 Baxter
12.2.1 Company Information
12.2.2 Intravenous Solution Compounder Product Offered
12.2.3 Baxter Intravenous Solution Compounder Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Baxter Latest Developments
12.3 B.Braun
12.3.1 Company Information
12.3.2 Intravenous Solution Compounder Product Offered
12.3.3 B.Braun Intravenous Solution Compounder Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 B.Braun Latest Developments
12.4 Grifols
12.4.1 Company Information
12.4.2 Intravenous Solution Compounder Product Offered
12.4.3 Grifols Intravenous Solution Compounder Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Grifols Latest Developments
12.5 ICU Medical
12.5.1 Company Information
12.5.2 Intravenous Solution Compounder Product Offered
12.5.3 ICU Medical Intravenous Solution Compounder Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 ICU Medical Latest Developments
12.6 Pfizer
12.6.1 Company Information
12.6.2 Intravenous Solution Compounder Product Offered
12.6.3 Pfizer Intravenous Solution Compounder Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Omnicell
12.7.1 Company Information
12.7.2 Intravenous Solution Compounder Product Offered
12.7.3 Omnicell Intravenous Solution Compounder Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Omnicell Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Intravenous Solution Compounder Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Countertop Intravenous Solution Compounder
Table 5. Major Players of Standalone Intravenous Solution Compounder
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Intravenous Solution Compounder Consumption Market Share by Type (2015-2020)
Table 8. Global Intravenous Solution Compounder Revenue by Type (2015-2020) ($ million)
Table 9. Global Intravenous Solution Compounder Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Intravenous Solution Compounder Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Intravenous Solution Compounder Consumption Market Share by Application (2015-2020)
Table 13. Global Intravenous Solution Compounder Value by Application (2015-2020)
Table 14. Global Intravenous Solution Compounder Value Market Share by Application (2015-2020)
Table 15. Global Intravenous Solution Compounder Sale Price by Application (2015-2020)
Table 16. Global Intravenous Solution Compounder Sales by Company (2017-2019) (K Units)
Table 17. Global Intravenous Solution Compounder Sales Market Share by Company (2017-2019)
Table 18. Global Intravenous Solution Compounder Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Intravenous Solution Compounder Revenue Market Share by Company (2017-2019)
Table 20. Global Intravenous Solution Compounder Sale Price by Company (2017-2019)
Table 21. Global Intravenous Solution Compounder Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Intravenous Solution Compounder Products Offered
Table 23. Intravenous Solution Compounder Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Intravenous Solution Compounder Consumption by Regions 2015-2020 (K Units)
Table 25. Global Intravenous Solution Compounder Consumption Market Share by Regions 2015-2020
Table 26. Global Intravenous Solution Compounder Value by Regions 2015-2020 ($ Millions)
Table 27. Global Intravenous Solution Compounder Value Market Share by Regions 2015-2020
Table 28. Americas Intravenous Solution Compounder Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Intravenous Solution Compounder Consumption Market Share by Countries (2015-2020)
Table 30. Americas Intravenous Solution Compounder Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Intravenous Solution Compounder Value Market Share by Countries (2015-2020)
Table 32. Americas Intravenous Solution Compounder Consumption by Type (2015-2020) (K Units)
Table 33. Americas Intravenous Solution Compounder Consumption Market Share by Type (2015-2020)
Table 34. Americas Intravenous Solution Compounder Consumption by Application (2015-2020) (K Units)
Table 35. Americas Intravenous Solution Compounder Consumption Market Share by Application (2015-2020)
Table 36. APAC Intravenous Solution Compounder Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Intravenous Solution Compounder Consumption Market Share by Countries (2015-2020)
Table 38. APAC Intravenous Solution Compounder Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Intravenous Solution Compounder Value Market Share by Regions (2015-2020)
Table 40. APAC Intravenous Solution Compounder Consumption by Type (2015-2020) (K Units)
Table 41. APAC Intravenous Solution Compounder Consumption Market Share by Type (2015-2020)
Table 42. APAC Intravenous Solution Compounder Consumption by Application (2015-2020) (K Units)
Table 43. APAC Intravenous Solution Compounder Consumption Market Share by Application (2015-2020)
Table 44. Europe Intravenous Solution Compounder Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Intravenous Solution Compounder Consumption Market Share by Countries (2015-2020)
Table 46. Europe Intravenous Solution Compounder Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Intravenous Solution Compounder Value Market Share by Countries (2015-2020)
Table 48. Europe Intravenous Solution Compounder Consumption by Type (2015-2020) (K Units)
Table 49. Europe Intravenous Solution Compounder Consumption Market Share by Type (2015-2020)
Table 50. Europe Intravenous Solution Compounder Consumption by Application (2015-2020) (K Units)
Table 51. Europe Intravenous Solution Compounder Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Intravenous Solution Compounder Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Intravenous Solution Compounder Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Intravenous Solution Compounder Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Intravenous Solution Compounder Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Intravenous Solution Compounder Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Intravenous Solution Compounder Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Intravenous Solution Compounder Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Intravenous Solution Compounder Consumption Market Share by Application (2015-2020)
Table 60. Intravenous Solution Compounder Distributors List
Table 61. Intravenous Solution Compounder Customer List
Table 62. Global Intravenous Solution Compounder Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Intravenous Solution Compounder Consumption Market Forecast by Regions
Table 64. Global Intravenous Solution Compounder Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Intravenous Solution Compounder Value Market Share Forecast by Regions
Table 66. Global Intravenous Solution Compounder Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Intravenous Solution Compounder Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Intravenous Solution Compounder Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Intravenous Solution Compounder Value Market Share Forecast by Type (2021-2025)
Table 70. Global Intravenous Solution Compounder Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Intravenous Solution Compounder Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Intravenous Solution Compounder Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Intravenous Solution Compounder Value Market Share Forecast by Application (2021-2025)
Table 74. ARxIUM Product Offered
Table 75. ARxIUM Intravenous Solution Compounder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. ARxIUM Main Business
Table 77. ARxIUM Latest Developments
Table 78. ARxIUM Basic Information, Company Total Revenue (in $ million), Intravenous Solution Compounder Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter Product Offered
Table 80. Baxter Intravenous Solution Compounder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. Baxter Main Business
Table 82. Baxter Latest Developments
Table 83. Baxter Basic Information, Company Total Revenue (in $ million), Intravenous Solution Compounder Manufacturing Base, Sales Area and Its Competitors
Table 84. B.Braun Product Offered
Table 85. B.Braun Intravenous Solution Compounder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. B.Braun Main Business
Table 87. B.Braun Latest Developments
Table 88. B.Braun Basic Information, Company Total Revenue (in $ million), Intravenous Solution Compounder Manufacturing Base, Sales Area and Its Competitors
Table 89. Grifols Product Offered
Table 90. Grifols Intravenous Solution Compounder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. Grifols Main Business
Table 92. Grifols Latest Developments
Table 93. Grifols Basic Information, Company Total Revenue (in $ million), Intravenous Solution Compounder Manufacturing Base, Sales Area and Its Competitors
Table 94. ICU Medical Product Offered
Table 95. ICU Medical Intravenous Solution Compounder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. ICU Medical Main Business
Table 97. ICU Medical Latest Developments
Table 98. ICU Medical Basic Information, Company Total Revenue (in $ million), Intravenous Solution Compounder Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Product Offered
Table 100. Pfizer Intravenous Solution Compounder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Pfizer Basic Information, Company Total Revenue (in $ million), Intravenous Solution Compounder Manufacturing Base, Sales Area and Its Competitors
Table 104. Omnicell Product Offered
Table 105. Omnicell Basic Information, Company Total Revenue (in $ million), Intravenous Solution Compounder Manufacturing Base, Sales Area and Its Competitors
Table 106. Omnicell Main Business
Table 107. Omnicell Latest Developments
Table 108. Omnicell Intravenous Solution Compounder Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
List of Figures
Figure 1. Picture of Intravenous Solution Compounder
Figure 2. Intravenous Solution Compounder Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Intravenous Solution Compounder Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Intravenous Solution Compounder Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Countertop Intravenous Solution Compounder
Figure 7. Product Picture of Standalone Intravenous Solution Compounder
Figure 8. Global Intravenous Solution Compounder Consumption Market Share by Type (2015-2020)
Figure 9. Global Intravenous Solution Compounder Value Market Share by Type (2015-2020)
Figure 10. Intravenous Solution Compounder Consumed in Hospital
Figure 11. Global Intravenous Solution Compounder Market: Hospital (2015-2020) (K Units)
Figure 12. Global Intravenous Solution Compounder Market: Hospital (2015-2020) ($ Millions)
Figure 13. Intravenous Solution Compounder Consumed in Clinic
Figure 14. Global Intravenous Solution Compounder Market: Clinic (2015-2020) (K Units)
Figure 15. Global Intravenous Solution Compounder Market: Clinic (2015-2020) ($ Millions)
Figure 16. Intravenous Solution Compounder Consumed in Others
Figure 17. Global Intravenous Solution Compounder Market: Others (2015-2020) (K Units)
Figure 18. Global Intravenous Solution Compounder Market: Others (2015-2020) ($ Millions)
Figure 19. Global Intravenous Solution Compounder Consumption Market Share by Application (2015-2020)
Figure 20. Global Intravenous Solution Compounder Value Market Share by Application (2015-2020)
Figure 21. Global Intravenous Solution Compounder Sales Market Share by Company in 2017
Figure 22. Global Intravenous Solution Compounder Sales Market Share by Company in 2019
Figure 23. Global Intravenous Solution Compounder Revenue Market Share by Company in 2017
Figure 24. Global Intravenous Solution Compounder Revenue Market Share by Company in 2019
Figure 25. Global Intravenous Solution Compounder Sale Price by Company in 2019
Figure 26. Global Intravenous Solution Compounder Consumption Market Share by Regions 2015-2020
Figure 27. Global Intravenous Solution Compounder Value Market Share by Regions 2015-2020
Figure 28. Americas Intravenous Solution Compounder Consumption 2015-2020 (K Units)
Figure 29. Americas Intravenous Solution Compounder Value 2015-2020 ($ Millions)
Figure 30. APAC Intravenous Solution Compounder Consumption 2015-2020 (K Units)
Figure 31. APAC Intravenous Solution Compounder Value 2015-2020 ($ Millions)
Figure 32. Europe Intravenous Solution Compounder Consumption 2015-2020 (K Units)
Figure 33. Europe Intravenous Solution Compounder Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Intravenous Solution Compounder Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Intravenous Solution Compounder Value 2015-2020 ($ Millions)
Figure 36. Americas Intravenous Solution Compounder Consumption Market Share by Countries in 2019
Figure 37. Americas Intravenous Solution Compounder Value Market Share by Countries in 2019
Figure 38. Americas Intravenous Solution Compounder Consumption Market Share by Type in 2019
Figure 39. Americas Intravenous Solution Compounder Consumption Market Share by Application in 2019
Figure 40. United States Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 41. United States Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Intravenous Solution Compounder Consumption Market Share by Countries in 2019
Figure 47. APAC Intravenous Solution Compounder Value Market Share by Regions in 2019
Figure 48. APAC Intravenous Solution Compounder Consumption Market Share by Type in 2019
Figure 49. APAC Intravenous Solution Compounder Consumption Market Share by Application in 2019
Figure 50. China Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 51. China Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 58. India Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 59. India Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Intravenous Solution Compounder Consumption Market Share by Countries in 2019
Figure 63. Europe Intravenous Solution Compounder Value Market Share by Countries in 2019
Figure 64. Europe Intravenous Solution Compounder Consumption Market Share by Type in 2019
Figure 65. Europe Intravenous Solution Compounder Consumption Market Share by Application in 2019
Figure 66. Germany Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 68. France Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 69. France Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 70. UK Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 71. UK Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Intravenous Solution Compounder Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Intravenous Solution Compounder Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Intravenous Solution Compounder Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Intravenous Solution Compounder Consumption Market Share by Application in 2019
Figure 80. Egypt Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Intravenous Solution Compounder Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Intravenous Solution Compounder Value Growth 2015-2020 ($ Millions)
Figure 90. Global Intravenous Solution Compounder Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Intravenous Solution Compounder Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 93. Americas Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 94. APAC Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 95. APAC Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 96. Europe Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 97. Europe Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 100. United States Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 101. United States Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 102. Canada Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 103. Canada Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 104. Mexico Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 105. Mexico Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 106. Brazil Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 107. Brazil Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 108. China Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 109. China Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 110. Japan Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 111. Japan Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 112. Korea Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 113. Korea Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 116. India Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 117. India Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 118. Australia Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 119. Australia Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 120. Germany Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 121. Germany Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 122. France Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 123. France Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 124. UK Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 125. UK Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 126. Italy Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 127. Italy Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 128. Russia Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 129. Russia Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 130. Spain Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 131. Spain Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 132. Egypt Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 133. Egypt Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 134. South Africa Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 135. South Africa Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 136. Israel Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 137. Israel Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 138. Turkey Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 139. Turkey Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Intravenous Solution Compounder Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Intravenous Solution Compounder Value 2021-2025 ($ Millions)
Figure 142. ARxIUM Intravenous Solution Compounder Market Share (2018-2020)
Figure 143. Baxter Intravenous Solution Compounder Market Share (2018-2020)
Figure 144. B.Braun Intravenous Solution Compounder Market Share (2018-2020)
Figure 145. Grifols Intravenous Solution Compounder Market Share (2018-2020)
Figure 146. ICU Medical Intravenous Solution Compounder Market Share (2018-2020)
Figure 147. Pfizer Intravenous Solution Compounder Market Share (2018-2020)
Figure 148. Omnicell Intravenous Solution Compounder Market Share (2018-2020)
※본 조사보고서 [세계의 정맥 용액 합성기 시장예측 2020년-2025년] (코드 : LPI20JL010317) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 정맥 용액 합성기 시장예측 2020년-2025년] 에 대해서 E메일 문의는 여기를 클릭하세요.